Why screening for the deadliest cancer in the U.S. misses most cases

Tuesday, November 25, 2025 -Despite advances in medical technology, screening for the deadliest cancer in the U.S. continues to miss a significant number of cases. 

Experts warn that current methods often fail to detect tumors early enough, leaving patients at risk of advanced-stage diagnoses when treatment options are more limited. The gap in effective detection is raising urgent calls for improved screening protocols.

Medical researchers point to several factors contributing to missed cases, including limitations in test sensitivity, inconsistent screening guidelines, and disparities in access to healthcare. 

Even patients who follow recommended screening schedules may receive false negatives, highlighting the critical need for more accurate and accessible diagnostic tools.

Healthcare professionals are emphasizing a multi-pronged approach: enhancing current screening methods, developing new technologies, and increasing public awareness about early warning signs. 

With cancer remaining a leading cause of death, experts stress that innovation and vigilance are key to saving lives and closing the gap in detection.